DanCann Pharma Management
Management criteria checks 1/4
DanCann Pharma's CEO is Jeppe Rasmussen, appointed in Jan 2018, has a tenure of 6.33 years. directly owns 3.55% of the company’s shares, worth DKK413.96K. The average tenure of the management team and the board of directors is 3.2 years and 2.4 years respectively.
Key information
Jeppe Rasmussen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.3yrs |
| CEO ownership | 3.5% |
| Management average tenure | 3.2yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO
Jeppe Rasmussen (28 yo)
6.3yrs
Tenure
Mr. Jeppe Krog Rasmussen has been Director of Dancann Pharma A/S since September 20, 2022. He Founded and serves as Chief Executive Officer of Dancann Pharma A/S since 2018 and serves as its Member of Exec...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.3yrs | no data | 3.55% DKK 414.0k | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Head of Production | 3.2yrs | no data | no data | |
| Chief Commercial Officer | 4.3yrs | no data | no data | |
| Head of Quality Assurance | 1.8yrs | no data | no data |
3.2yrs
Average Tenure
Experienced Management: DANCAN's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 1.7yrs | no data | 3.55% DKK 414.0k | |
| Chairman of the Board | 4.3yrs | no data | 0.25% DKK 28.6k | |
| Vice-Chairman | 3.1yrs | no data | 0.15% DKK 16.9k | |
| Additional Director | less than a year | no data | no data |
2.4yrs
Average Tenure
39yo
Average Age
Experienced Board: DANCAN's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.